UCLA Researchers & Innovators
Industry & Investors
News & Events
About
Concierge
Search Results - patricia+spilman
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
2018-200 AMYLOID PRECURSOR PROTEIN-SELECTIVE BACE INHIBITORS (ASBIS) FOR ALZHEIMER’S DISEASE
Amyloid Precursor Protein-Selective BACE Inhibitors for Alzheimer’s DiseaseSUMMARYUCLA researchers in the Department of Neurology have invented novel Alzheimer’s disease (AD) therapeutics that are selective for BACE1 inhibition and cleavage of the amyloid precursor protein (APP) substrate.BACKGROUNDAlzheimer’s disease is characterized...
Published: 7/19/2023
|
Inventor(s):
Barbara Jagodzinska
,
Varghese John
,
Patricia Spilman
,
Jesus Campagna
Keywords(s):
Cns
,
Life Science Research Tools
,
Medical Devices and Materials
,
Targets And Assays
,
Therapeutics & Vaccines
Category(s):
Life Science Research Tools
,
Diagnostic Markers > Targets And Assays
,
Medical Devices
,
Therapeutics
,
Therapeutics > CNS and Neurology
2016-305 New 3D-Exoquant Method for the Analysis of Surface Molecules and Quantification of Tissue-Specific Exosomes in Biological Fluids
SUMMARYUCLA researchers in the Department of Neurology have developed a novel high sensitivity exosome and extracellular vesicle disease detection technology for use in the clinical and research setting. BACKGROUNDDetection of surface biomarkers located on extracellular bodies, such as vesicles and exosomes is of great clinical and research significance...
Published: 7/19/2023
|
Inventor(s):
Varghese John
,
Patricia Spilman
,
Jesus Campagna
,
Peter Heinzelman
,
Tina Bilousova
Keywords(s):
Diagnostic Markers & Platforms
,
Diagnostic Platform Technologies (E.G. Microfluidics)
Category(s):
Diagnostic Markers
,
Platforms > Diagnostic Platform Technologies
2017-772 ALLOSTERIC BACE INHIBITORS FOR TREATMENT OF ALZHEIMER’S DISEASE
Allosteric BACE Inhibitors For Treatment Of Alzheimer’s DiseaseSUMMARYUCLA researchers from the Department of Neurology have discovered a new class of drug candidates for Alzheimer’s disease. These small molecule compounds can specifically inhibit target enzymes to prevent target protein cleavage through an allosteric mechanism, preventing...
Published: 9/5/2023
|
Inventor(s):
Varghese John
,
Barbara Jagodzinska
,
Patricia Spilman
,
Jesus Campagna
,
Kanagasabai Vadivel
,
Michael Jung
Keywords(s):
Cns
,
Therapeutics & Vaccines
Category(s):
Therapeutics
,
Therapeutics > CNS and Neurology